- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Reneo Pharmaceuticals is a biotechnology business based in the US. Reneo Pharmaceuticals shares (RPHM) are listed on the NASDAQ and all prices are listed in US Dollars. Reneo Pharmaceuticals employs 8 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Reneo Pharmaceuticals stock
- Trade $0 commission stocks, ETFs, and options with as little as $1
- After-hours trading available
- Earn 4.5% interest on uninvested cash with Gold
- 24/7 customer support
- $0 commission trading
- Instant withdrawals with a 1.75% fee
- Supports 250+ cryptocurrencies
- High-yield account earns up to 4.65% APY
Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.
How to buy Reneo Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RPHM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Reneo Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Reneo Pharmaceuticals stock price (NASDAQ: RPHM)
Use our graph to track the performance of RPHM stocks over time.Reneo Pharmaceuticals shares at a glance
52-week range | $9.80 - $77.60 |
---|---|
50-day moving average | $14.92 |
200-day moving average | $16.09 |
Wall St. target price | $2.25 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-16.80 |
Is it a good time to buy Reneo Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Reneo Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -33.72% |
Return on equity TTM | -54% |
Profit margin | 0% |
Book value | $23.00 |
Market Capitalization | $60.8 million |
TTM: trailing 12 months
Reneo Pharmaceuticals share dividends
We're not expecting Reneo Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
Have Reneo Pharmaceuticals's shares ever split?
Reneo Pharmaceuticals's shares were split on a 1:10 basis on 6 October 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Reneo Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Reneo Pharmaceuticals shares which in turn could have impacted Reneo Pharmaceuticals's share price.
Reneo Pharmaceuticals share price volatility
Over the last 12 months, Reneo Pharmaceuticals's shares have ranged in value from as little as $9.801 up to $77.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Reneo Pharmaceuticals's is 0.22. This would suggest that Reneo Pharmaceuticals's shares are less volatile than average (for this exchange).
To put Reneo Pharmaceuticals's beta into context you can compare it against those of similar companies.
- Atara Biotherapeutics (ATRA.US): 0.495
- Generation Bio Co (GBIO.US): 2.818
- Akouos Inc (AKUS.US): -0.5613
Reneo Pharmaceuticals overview
Reneo Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California. .
Frequently asked questions
What percentage of Reneo Pharmaceuticals is owned by insiders or institutions?Currently 5.188% of Reneo Pharmaceuticals shares are held by insiders and 87.751% by institutions. How many people work for Reneo Pharmaceuticals?
Latest data suggests 8 work at Reneo Pharmaceuticals. When does the fiscal year end for Reneo Pharmaceuticals?
Reneo Pharmaceuticals's fiscal year ends in December. Where is Reneo Pharmaceuticals based?
Reneo Pharmaceuticals's address is: 18575 Jamboree Road, Irvine, CA, United States, 92612 What is Reneo Pharmaceuticals's ISIN number?
Reneo Pharmaceuticals's international securities identification number is: US75974E1038
More guides on Finder
-
Best Paper Trading Apps to Practice Trading With Fake Money in 2024
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
-
5 Best International Stock Brokers to Invest in Foreign Assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
9 Best Robo-Advisors for Automatic Investing
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Betterment alternatives
5 Betterment robo-advisor alternatives to consider when building your portfolio.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to gift stock
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
Acorns review 2024
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.
Ask a question